LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 5 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 2. - Dataset (ID:20313)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 90.40 | 19.50 | 2687 | 6097 | 0.4408 | 0.4501 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 92.30 | 19.50 | 2741 | 6153 | 0.4456 | 0.4479 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 94.30 | 19.50 | 2800 | 6154 | 0.4553 | 0.4451 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 2.70 | 19.50 | 198 | 163 | 1.1970 | 0.5873 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 4.60 | 19.50 | 295 | 295 | 0.9938 | 0.4819 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 6.60 | 19.50 | 351 | 390 | 0.9003 | 0.4831 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.60 | 19.50 | 369 | 442 | 0.8357 | 0.4868 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.60 | 19.50 | 389 | 467 | 0.8344 | 0.5120 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.50 | 19.50 | 402 | 495 | 0.8115 | 0.5210 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.50 | 19.50 | 412 | 537 | 0.7668 | 0.4841 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.50 | 19.50 | 419 | 626 | 0.6745 | 0.4543 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.40 | 19.50 | 433 | 775 | 0.5610 | 0.4476 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.40 | 19.50 | 436 | 951 | 0.4622 | 0.4560 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.40 | 19.50 | 440 | 1150 | 0.3850 | 0.3820 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.30 | 19.50 | 471 | 1322 | 0.3553 | 0.3885 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 26.30 | 19.50 | 498 | 1491 | 0.3336 | 0.3886 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 28.30 | 19.50 | 524 | 1665 | 0.3144 | 0.3996 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.30 | 19.50 | 553 | 1887 | 0.2934 | 0.3879 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.20 | 19.50 | 579 | 2123 | 0.2731 | 0.3833 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.20 | 19.50 | 596 | 2452 | 0.2450 | 0.3532 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.20 | 19.50 | 622 | 2641 | 0.2363 | 0.3554 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.10 | 19.50 | 652 | 2867 | 0.2282 | 0.4096 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 40.10 | 19.50 | 672 | 3104 | 0.2169 | 0.3981 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.10 | 19.50 | 699 | 3461 | 0.2027 | 0.3897 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.00 | 19.50 | 725 | 3824 | 0.1904 | 0.3863 |